Summary Cell viability following short (1 h) contact with paclitaxel or docetaxel was assayed using synchronised HeLa cells. Docetaxel proved almost totally lethal against S-phase cells. Its toxicity was only partial against cells in mitosis. and declined to a minimum with progression to GI. For paclitaxel. cytotoxicity increased with progression through S and G,, peaked at the time of mitosis. and decreased thereafter. Maximum resistance to paclitaxel was in early S. Although lethal, brief exposure to docetaxel in S-phase did not delay progression through S and G2. (Extra et al., 1993; Rowimsky et al., 1992).
Paclitaxel (Taxol) and docetaxel (Taxotere) are the first of a new class of microtubule-targeting anti-tumour diterpenoids currently referred to as taxoids ( Figure 1 ). Paclitaxel (PAC) was first isolated from the bark of the Pacific yew Taxus brevifolia (Wani et al., 1971) . Docetaxel (DOC) is a new taxoid obtained from chemical synthesis from 10-deacetylbaccatin III, a taxoid extracted from a renewable source, the needles of the English yew Taxus baccata (Mangatal et al., 1989; Gueritte-Voegelein et al., 1991) . PAC and DOC are highly cytotoxic against proliferating mammalian cells in vitro (Hanauske et al., 1992; Kelland and Abel, 1992; Riou et al., 1992) . DOC reportedly cures transplantable tumours in mice (Bissery et al., 1991) , and both PAC and DOC have proved active in the treatment of ovarian, breast and lung cancer in humans (Extra et al., 1993; Rowimsky et al., 1992) .
The elucidation of the mode of action of taxoids is of great interest in consideration of their promising anti-tumour potential. PAC in the micromolar range is a promoter of tubulin polymenrsation, thus decreasing the critical concentration of tubulin required for the self-assembly of microtubules (Schiff et al., 1979) in the absence of microtubule-associated proteins and of GTP (Schiff and Horwitz, 1981) . PAC also stabilises microtubules against disruption by nocodazole (Amin-Hanjani et al., 1991), by calcium chloride (Thompson et al., 1981) and by cold in the test tube and in cells (Schiff et al., 1979; Schiff and Horwitz, 1980) . Finally, PAC binds specifically and reversibly to polymenrsed forms of tubulin with stoichiometry close to unity (Parness and Horwitz, 1981) , promotes the reorganisation of the microtubule network into dense bundles or asters (De Brabander et al., 1981a; Roberts et al., 1989) and induces complex arrays of cross-bridged microtubules and intermediate filaments (Geuens et al.. 1983; Green and Goldman, 1983) . DOC produces the same effects as PAC on the microtubule system, yet it appears more potent than PAC on a molar basis (Gueritte-Voegelein et al., 1991; Ringel and Horwitz, 1991; Horwitz, 1992; Diaz and Andreu, 1993) . These effects have been proposed to play a major role in the antineoplastic activity of PAC (Rowinsky et al., 1988) ; however, they are not observed unless cells are exposed for extended lengths of time to supralethal amounts of drug (Amin-Hanjani et al., 1991) . and attempts at identifying the mode of action of taxoids in living cells from studies in the test tube should take into consideration the capability of cells to accumulate these drugs in large excess over the medium (Jordan et al., 1993; Riou et al., 1994) .
Exposure of human cells to PAC brings about a sustained block at the metaphase-anaphase boundary. This again requires prolonged, continuous contact with lethal amounts of drug, and large differences in the efficiency of the mitotic block occur among cell lines (Gupta, 1985; Roberts et al.. 1990) ; in some instances drug-treated cells escape the mitotic block without cytokinesis and give rise to multinucleated, non-viable cells (Jordan et al., 1993 
Treatments
For colony formation assays, 600-1200 cells from 4-day-old mid-log phase subcultures were plated in tnpphcate or more in 25 cm2 flasks, and allowed to adhere and spread for 4 h in the incubator before treatment. Following drug exposure, the flasks were rinsed and cells returned to normal growth medium for 10 -11 days. Colonies were fixed with methanol. stained and scored visually.
For determination of the growth-inhibitory effect of drugs. 1-to 2-day-old exponentially growing cultures (c. I0$ cells cm-2) were exposed to drug. washed and incubated in drugfree medium for 5 days. Colonies were then dislocated by trypsin. cells were collected by centrifugation. resuspended and scored with a model 256 Coulter counter.
Exposure to PAC or DOC was carried out in dim light to prevent photodegradation of the drugs. Contact with either drug was for I h. unless otherwise stated. Drugs were carefully removed by two washes with Hanks' balanced saline (37C) at 3-4 min intervals and cells were returned to normal growth medium.
U'ptake and efflux of DOC Incorporation and release of DOC were probed using [propionyl-3-'4C] DOC at concentrations ranging between 20 nM (0.94 nCi ml-') and 200 nM (9.4 nCi ml-') and cell densities of 4 x 104 to 8 x I0 cells cm-' (25 cm-flasks). Following contact with drug for the desired times (up to 4 h). the flasks were carefully rinsed twice with 10 ml of warm Hanks' balanced saline solution. and once with complete growth medium. Flasks were rinsed again before lysis. Lysis was achieved by addition of 2 ml of 50 mM Tris-HCl. 2% lauryl sulphate solution. pH 7.8. and the lysates counted by scintillation. Cells were scored using replicate samples grown and treated in parallel.
Where required. depolymerisation of microtubules before contact with DOC was achieved in the same way as described for P-388 cells (Riou et al., 1994 (Figures 2 and 3 ) matches exactly that known for PAC (Jordan et al., 1993; Lopes et al., 1993) , in spite of the large difference in the IC,o range for both drugs ( Figure   4 ). In contrast. PAC and DOC given in short incubation demonstrate large differences in the cell cycle phase specificity of their cytotoxic potential against synchronised HeLa cells ( is lethal but not sufficient to block cells at a premitotic stage; the block is not operating unless DOC is reintroduced shortly before mitosis. This suggests that cell killing and arrest of cell cycle progression at prometaphase by DOC proceed from distinct time-related mechanisms. Maximum toxicity of PAC is at mitosis, in agreement with the findings of others (Donaldson et al.. 1994; Geard and Jones, 1994; Long and Fairchild, 1994) , and consistent with the mitotic spindle apparatus forming the main target of PAC. This occurs irrespective of whether synchronisation of cells is achieved using serum stimulation of quiescent cells (Donaldson et al.. 1994) , mitotic shake-off selection (Geard and Jones, 1994) . nocodazole treatment (Long and Fairchild, 1994) or double thymidine block ( Figure 5 ).
HeLa cells incorporate very large amounts of DOC in excess over the medium, in the same way as reported with PAC (Jordan et al., 1993) . We consequently determined the kinetics of drug uptake and efflux in order to address the possibility that slow drug release would skew the sensitivity profile of synchronised HeLa cells progressing through the cell cycle. We found that the efflux of DOC is biphasic, with a rapid, comparatively minor (15%) phase preceding slow release of the major (85%) drug fraction. We tentatively assign rapid efflux to a membrane compartment. The major compartment presumably corresponds to tight binding of the drug to microtubules (Riou et al., 1994) (1) Pulse exposure (I h) to DOC at the concentrations used in our experiments is not sufficient to induce gross alteration of the microtubule network and of the mitotic spindle (Jordan et al., 1993 ). yet binding of taxoids seems to occur preferentially on microtubules (Parness and Horwitz, 1981: Riou et al., 1994) and could alter their dynamics (Jordan et al., 1993) .
(2) As shown in Figure 5 . the toxicity of DOC introduced at the time of mitosis. or shortly before, is not as absolute as during S-phase. (3) There is no change in the susceptibility to DOC throughout S-phase. (4) Drug uptake does not vary appreciably with progression of cells through the cell cycle. (5) Pulse-chase treatment with DOC at any time from early to late S-phase, does not result in alteration of the cell cycle progression for up to prometaphase.
Furthermore, despite slow drug efflux. S-phase-treated cells will not arrest at prometaphase unless DOC is reintroduced shortly before mitosis. We suggest. therefore. that in addition to slower efflux kinetics. DO}C targets more efficiently and more specifically than PAC some crucial system or organelle whose expression or maturation occurs in S-phase. and whose integrity would be essential to orderly progression through mitosis and cytokinesis.
Centrosome, whose elongation in synchronised HeLa cells extends throughout S-phase following separation of the parent procentrioles in late GI (Robbins et al.. 1968: Kuriyama and Borisy, 1981) , appears to be the best candidate to meet these requirements (for a review see Tourmier and Bornens. 1994). Centrosome targeting was already proposed, years ago, to account for the S-phase specificity of mitotic cell death induction by vinblastine (Madoc-Jones and Mauro, 1968) . Vinblastine and vincristine are inducers of microtubule depolymerisation. but they may also promote the formation of tubulin paracrystals (Na and Timasheff. 1982; Prakash and Timasheff. 1983; Skoda et al.. 1983) . and other authors have suggested that the cytotoxic effects of Vinca alkaloids could be brought about by mechanisms upstream of the mitotic spindle formation (Jordan et al., 1991) . Damage to kinetochores is another possibility (De Brabander et al., 1981b) . In a forthcoming paper direct evidence will be given, based on immunofluorescence staining in synchronised HeLa cells, of hindered centrosomal function by DOC in relation to cell cycle progression. Abbreviations PAC. paclitaxel; DOC. docetaxel.
